Hematology & Oncology Doctors in Bossier City, LA Accepting Medicare

2 Hematology & Oncology doctors found. Showing 1 - 2

Neelima Chintapalli, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2539 Viking Dr, Bossier City, LA 71111 Phone: 318-848-2970    Fax: 318-848-2971

Dr. Robert J Massingill, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2539 Viking Dr, Bossier City, LA 71111 Phone: 318-848-2970    Fax: 318-848-2971

News Archive

Vitamin D supplementation during pregnancy prevents autism traits in offspring

Giving vitamin D supplements to mice during pregnancy prevents autism traits in their offspring, University of Queensland researchers have discovered.

Mammogram for women over 40: Debate continues

A report this Wednesday showed that routine screenings for breast cancer called mammograms cut the breast cancer death rate by 26 percent for women in their 40s. The results have been received in a mixed way by experts.

New system detects residues of livestock drugs in baby food preparations

The quantities are very small, but in milk powder and in meat-based baby food, residues of drugs given to livestock were found. Researchers from the University of Almeria have developed a system to analyse these substances quickly and precisely.

Study identifies new blood markers to accurately diagnose Gulf War Illness

Based on a study of 85 Gulf War veterans, Veterans Affairs researchers in Minneapolis have developed a tentative panel of blood markers they say can verify a diagnosis of Gulf War Illness with 90 percent accuracy.

Trophos awarded US patent covering use of novel cardioprotective compound

Trophos SA a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, announced today that the United States Patent and Trademark Office (USPTO) has granted a patent for the use of their novel mitochondrial pore modulator, TRO40303, for cytoprotection. The patent provides coverage for the use of Trophos' TRO40303 to reduce the cardiac reperfusion injury that contributes significantly to the morbidity and mortality seen after a heart attack (myocardial infarction - MI).

Read more Medical News

› Verified 5 days ago